A recent study shows that diabetics with poor reaction to an anti-anemia drug may also experience higher risks of heart disease. Researchers at the UT Southwestern Medical Center found out that patients with diabetes, kidney problems as well as anemia who do not respond well to treatment using a drug called darbepoetin alpha also has a higher risk of cardiovascular disease and even death. Darbepoetin alpha is a dru